CSIMarket
 

Agentix Corp   (FWDR)

Agentix 's

Competitiveness




 

FWDR Sales vs. its Competitors Q1 2026



Comparing the current results to its competitors, Agentix reported Revenue decrease in the 1 quarter 2026 year on year by 0 %, slower than the combined decrease of the FWDR's competitors by -0.3 %, recorded in the same quarter.

List of FWDR Competitors





Revenue Growth Comparisons




Net Income Comparison


Agentix Corp , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 22.33 %

<<  FWDR Stock Performance Comparisons


Agentix 's Comment on Competition and Industry Peers


Agentix operates in the biopharmaceutical industry, which is characterized by rapid growth and intense global competition. The company competes with major firms including Novo Nordisk A/S, Johnson & Johnson, Pfizer, Inc., Hoffmann-La Roche, Eli Lilly and Company, Ltd., Biogen, Inc., Merck & Co., Inc., Sanofi, Bristol Myers Squibb Company, and Bayer AG. Agentix protects its proprietary rights—primarily brand names, product designs, and marks—through trademark laws, trade secrets, confidentiality provisions, and contractual measures. The company does not currently hold any patents.



*Market share is calculated based on total revenue.





Publicly Traded Peers of Agentix Corp




Alpha Pro Tech Ltd
Share Performance



+21.10%
This Year



Alpha Pro Tech Ltd
Profile

Alpha Pro Tech Ltd is a company that develops, manufactures, and distributes a range of disposable protective apparel, building supply products, and infection control products for the healthcare industry. They generate revenue by selling these products to various customers, including hospitals, distributors, and other industries.

More about Alpha Pro Tech Ltd 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 57.016 mill. $ 62.204 mill. $ 9.757 mill.


Biogen Inc
Share Performance



+6.75%
30 Days



Biogen Inc
Profile

Biogen Incs business model focuses on researching, developing, and commercializing innovative therapies primarily for neurological and neurodegenerative diseases, emphasizing advancements in precision medicine and patient care.

More about Biogen Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 32,150.860 mill. $ 9,937.400 mill. $ 1,371.900 mill.


Bristol myers Squibb Company
Share Performance



+2.30%
30 Days



Bristol myers Squibb Company
Profile

Bristol Myers Squibb Company operates a research and development-driven business model, focusing on the discovery and delivery of innovative medicines for various diseases. It emphasizes collaboration with academic institutions, government entities, and other pharmaceutical firms to enhance its therapeutic portfolio and improve patient outcomes.

More about Bristol myers Squibb Company's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 136,760.070 mill. $ 48,482.000 mill. $ 7,271.000 mill.


Honeywell International Inc
Share Performance



-0.58%
Over The Past 5 Days



Honeywell International Inc
Profile

Honeywell International Inc operates as a diversified technology and manufacturing company, providing a broad portfolio of products and solutions across multiple sectors including aerospace, buildings, materials, and safety. The company emphasizes innovation and efficiency, leveraging advanced technologies to enhance productivity and sustainability for its customers. By integrating software and hardware in its offerings, Honeywell aims to deliver comprehensive solutions that drive operational excellence and long-term growth.

More about Honeywell International Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 68,030.658 mill. $ 36,130.000 mill. $ 8,217.000 mill.


Lakeland Industries Inc
Share Performance



+2.02%
30 Days



Lakeland Industries Inc
Profile

Lakeland Industries Inc's business model is to design, manufacture, and distribute a wide range of safety garments and protective clothing for various industries and hazards.

More about Lakeland Industries Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 119.718 mill. $ 193.318 mill. $ -21.029 mill.

4 more competitors available

Sign in to see all competitors

Sources: Agentix Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Agentix Corp versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.